Centaurus Financial Inc. Has $316,000 Stock Holdings in McKesson Co. (NYSE:MCK)

Centaurus Financial Inc. grew its position in McKesson Co. (NYSE:MCK – Get Rating) by 70.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 930 shares of the company’s stock after acquiring an additional 383 shares during the quarter. Centaurus Financial Inc.’s holdings in McKesson were worth $316,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Covestor Ltd boosted its stake in McKesson by 72.3% during the first quarter. Covestor Ltd now owns 81 shares of the company’s stock worth $25,000 after buying an additional 34 shares in the last quarter. Almanack Investment Partners LLC. acquired a new stake in shares of McKesson during the 3rd quarter valued at about $41,000. Worth Asset Management LLC bought a new stake in McKesson in the first quarter valued at about $41,000. Orion Capital Management LLC acquired a new position in McKesson in the third quarter worth about $49,000. Finally, Fairfield Bush & CO. bought a new position in McKesson during the first quarter worth about $46,000. 85.23% of the stock is currently owned by institutional investors.

McKesson Stock Down 0.2 %

Shares of NYSE MCK opened at $339.35 on Friday. McKesson Co. has a 12-month low of $292.40 and a 12-month high of $401.78. The firm’s 50-day simple moving average is $362.87 and its 200 day simple moving average is $366.41. The company has a market cap of $46.47 billion, a price-to-earnings ratio of 15.52, a price-to-earnings-growth ratio of 1.25 and a beta of 0.59.

McKesson (NYSE:MCK – Get Rating) last announced its earnings results on Wednesday, February 1st. The company reported $6.90 earnings per share for the quarter, topping analysts’ consensus estimates of $6.36 by $0.54. McKesson had a net margin of 1.15% and a negative return on equity of 216.12%. The company had revenue of $70.49 billion during the quarter, compared to the consensus estimate of $70.98 billion. During the same period in the previous year, the firm posted $6.15 earnings per share. The company’s revenue was up 2.7% on a year-over-year basis. On average, equities analysts expect that McKesson Co. will post 25.93 earnings per share for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 3rd. Shareholders of record on Wednesday, March 1st will be issued a dividend of $0.54 per share. The ex-dividend date is Tuesday, February 28th. This represents a $2.16 annualized dividend and a yield of 0.64%. McKesson’s dividend payout ratio is currently 9.88%.

Insider Activity at McKesson

In related news, CEO Brian S. Tyler sold 7,416 shares of McKesson stock in a transaction that occurred on Thursday, February 2nd. The shares were sold at an average price of $380.00, for a total transaction of $2,818,080.00. Following the transaction, the chief executive officer now owns 75,737 shares of the company’s stock, valued at approximately $28,780,060. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Brian S. Tyler sold 7,416 shares of the firm’s stock in a transaction on Thursday, February 2nd. The stock was sold at an average price of $380.00, for a total transaction of $2,818,080.00. Following the sale, the chief executive officer now owns 75,737 shares of the company’s stock, valued at approximately $28,780,060. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Nancy Avila sold 161 shares of the business’s stock in a transaction dated Friday, February 3rd. The shares were sold at an average price of $370.02, for a total value of $59,573.22. Following the completion of the transaction, the executive vice president now directly owns 4,631 shares of the company’s stock, valued at $1,713,562.62. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MCK. UBS Group lowered their price objective on McKesson from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Tuesday, January 31st. StockNews.com started coverage on McKesson in a research note on Thursday. They set a “strong-buy” rating for the company. Morgan Stanley boosted their target price on shares of McKesson from $420.00 to $426.00 and gave the company an “overweight” rating in a research note on Thursday, February 2nd. Finally, Robert W. Baird increased their target price on shares of McKesson from $445.00 to $450.00 and gave the stock an “outperform” rating in a research report on Thursday, February 2nd. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $416.30.

McKesson Profile

(Get Rating)

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).